Both Mounjaro (tirzepatide) from Eli Lilly, and Ozempic (semaglutide) from Novo Nordisk, are currently approved to help control blood glucose (sugar) levels in patients with type 2 diabetes, when used in addition to a diet plan and regular exercise. Ozempic is also approved to reduce the r...